Aeglea BioTherapeutics, Inc. (AGLE) Earnings
|
Expand Research on AGLE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -219.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/23 | Q323 | -$9.34 | -$0.92 | -$8.42 | N/A | $198K | N/A |  | | Details | |
| 8/9/23 | Q223 | N/A | -$0.14 | N/A | N/A | $198K | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | N/A | -$0.19 | N/A | N/A | $172.67K | N/A | N/A | N/A | ||
| 3/15/23 | Q422 | N/A | -$0.23 | N/A | N/A | $66.67K | N/A | N/A | N/A | ||
| 11/3/22 | Q322 | -$0.31 | -$0.24 | -$0.07 | $1.4M | $150K | N/A | | | Details | |
| 8/4/22 | Q222 | -$0.10 | -$0.31 | +$0.21 | $13.7M | $567.6K | N/A | | | Details |
